STRATA Skin Sciences (SSKN) Receivables (2012 - 2025)

STRATA Skin Sciences has disclosed Receivables across 14 years of filings, most recently posting $4.1 million for Q4 2025.

• Receivables for Q4 2025 came in at $4.1 million, down 21.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.1 million (down 21.55% YoY), and the FY2025 annual result was $4.1 million, down 21.55% from the prior year.
• Receivables came in at $4.1 million for Q4 2025 at STRATA Skin Sciences, up from $3.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $5.3 million in Q4 2024 to a low of $2.9 million in Q1 2021.
• The 5-year median for Receivables is $3.9 million (2023), against an average of $3.9 million.
• Across the five-year window, Receivables surged 1327.0% in 2021 and decreased 21.55% in 2025, its largest moves.
• STRATA Skin Sciences' Receivables stood at $3.4 million in 2021, then jumped by 30.24% to $4.5 million in 2022, then decreased by 0.69% to $4.4 million in 2023, then climbed by 18.31% to $5.3 million in 2024, then slipped by 21.55% to $4.1 million in 2025.
• The last three Receivables figures came in at $4.1 million (Q4 2025), $3.5 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.